Interrelationship between reduction in weight and adiposity indices and improvement in cardiovascular death and heart failure outcomes with empagliflozin in patients with type 2 diabetes in EMPAREG outcome

Category Primary study
JournalCirculation
Year 2017
This article has no abstract
Epistemonikos ID: 007cbff82b818bf0faf476273d643a9f3f9e51ed
First added on: Feb 08, 2025